Showing results (201-210 of 550) with videos related to
Sort By:
Pageof 55
The Journal of Biological Chemistry|May 5, 2023
The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activitySahezeel Awadia, Merna Sitto, Sundaresh Ram, et al.Neoplasia (New York, N.Y.)|July 13, 2012
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibitionVenkatasubbaiah A Venkatesha, Leslie A Parsels, Joshua D Parsels, et al.International Journal of Radiation Oncology, Biology, Physics|July 25, 2025
The Contribution of Cirrhosis Progression in Liver Dysfunction After Stereotactic Body Radiation TherapyAlex K Bryant, John D Rice, Emily Morris, et al.International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic MetastasesWilliam C Jackson, Yebin Tao, Mishal Mendiratta-Lala, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignanciesEdgar Ben-Josef, Daniel Normolle, William D Ensminger, et al.International Journal of Radiation Oncology, Biology, Physics|January 3, 2012
Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancerKlaudia U Hunter, Felix Y Feng, Kent A Griffith, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapyMatthew H Stenmark, Xu-Wei Cai, Kerby Shedden, et al.The Journal of Biological Chemistry|March 14, 2020
The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activityWei Huang, Paramita Ray, Wenbin Ji, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of HepatotoxicityMatthew M Cousins, Theresa P Devasia, Christopher M Maurino, et al.Neoplasia (New York, N.Y.)|November 21, 2015
Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination RepairTasneem Kausar, Jason S Schreiber, David Karnak, et al.Pageof 55